Endocrine disruptors and pharmaceuticals: Implications for water sustainability

Water Science and Technology

Volumn 61, Issue 1, 2010, Pages 145-154

  Snyder, Shane A ^a   Benotti, Mark J ^a  

^a SOUTHERN NEVADA WATER AUTHORITY   (United States)

Author keywords

Drinking water quality; Endocrine disruptors; Environmental impacts; Pharmaceuticals; Potable water; Water quality

Indexed keywords

ENVIRONMENTAL IMPACT; HEALTH RISKS; SURFACE WATERS; WASTEWATER; WATER DISTRIBUTION SYSTEMS; WATER POLLUTION; WATER QUALITY;

DRINKING WATER; DRINKING WATER QUALITY; ECOLOGICAL EFFECT; ENDOCRINE DISRUPTING COMPOUND; ENDOCRINE DISRUPTOR; ENDOCRINE DISRUPTORS; ENVIRONMENTAL BEHAVIOR; ENVIRONMENTAL CONCENTRATION; FATE AND TRANSPORT; FRESH WATER; HUMAN EXPOSURES; HUMAN HEALTH; HUMAN POPULATION; NATURAL SURFACE; NEVADA , USA; PHARMACEUTICALS; RISK TO HUMAN HEALTH; SCIENTIFIC COMMUNITY; WATER SUSTAINABILITY;

POTABLE WATER;

DRINKING WATER; DRUG; ENDOCRINE DISRUPTOR; FRESH WATER; SURFACE WATER; MEPROBAMATE; SULFAMETHOXAZOLE;

DRINKING WATER; DRUG; ENDOCRINE DISRUPTOR; ENVIRONMENTAL IMPACT; HEALTH RISK; MEDICAL GEOGRAPHY; POLLUTANT TRANSPORT; PUBLIC HEALTH; WATER QUALITY;

CLIMATE CHANGE; CONFERENCE PAPER; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT ASSESSMENT; ENVIRONMENTAL SUSTAINABILITY; POLLUTION MONITORING; RISK ASSESSMENT; UNITED STATES; WASTE WATER; WATER FLOW; WATER MANAGEMENT; WATER POLLUTANT; WATER QUALITY; ARTICLE; DROUGHT; HUMAN; RISK FACTOR; RIVER; SEASON; STANDARD; WATER SUPPLY;

LAKE MEAD; NEVADA; UNITED STATES;

COLORADO; DROUGHTS; ENDOCRINE DISRUPTORS; FRESH WATER; HUMANS; MEPROBAMATE; PHARMACEUTICAL PREPARATIONS; RISK FACTORS; RIVERS; SEASONS; SULFAMETHOXAZOLE; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 77950356025     PISSN: 02731223     EISSN: None     Source Type: Book Series    
DOI: 10.2166/wst.2010.791     Document Type: Article

References (41)

1. Adams, C., Wang, Y., Loftin, K. & Meyer, M. 2002 Removal of antibiotics from surface and distilled water in conventional water treatment processes. J. Environ. Eng.-ASCE 128(3), 253-260.
2. Barnett, T. P. & Pierce, D. W. 2008 When will Lake Mead go dry? Water Resour. Res. 44(3), W03201.
3. Barnett, T. P., Pierce, D. W., Hidalgo, H. G., Bonfils, C., Santer, B. D., Das, T., Bala, G., Wood, A. W., Nozawa, T., Mirin, A. A., Cayan, D. R. & Dettinger, M. D. 2008 Human-induced changes in the hydrology of the western United States. Science 319(5866), 1080-1083.
4. Benotti, M. J., Stanford, B. D. & Snyder, S. A. 2009a Increased loading of pharmaceuticals and endocrine disrupting compounds to source drinking water due to climate change. J. Environ. Qual., (in press).
5. Benotti, M. J., Trenholm, R. A., Vanderford, B. J., Holady, J. C., Stanford, B. D. & Snyder, S. A. 2009b Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ. Sci. Technol. 43(3), 597-603.
6. Bevans, H. E., Goodbred, S. L., Miesner, J. F., Watkins, S. A., Gross, T. S. Denslow, N. D. & Choeb, T. 1996 Synthetic Organic Compounds and Carp Endocrinology and Histology in Las Vegas Wash and Las Vegas and Callville Bays of Lake Mead, Nevada, 1992 and 1995, U.S. Geological Survey: 12.
7. Bruchet,A., Hochereau, C., Picard, C.,Decottignies,V.,Rodrigues, J.M. & Janex-Habibi, M. L. 2005 Analysis of drugs and personal care products in French source and drinking waters: the analytical challenge and examples of application. Water Sci. Technol. 52(8), 53-61.
8. D'Ascenzo, G., Di Corcia, A., Gentili, A., Mancini, R., Mastropasqua, R., Nazzari, M. & Samperi, R. 2003 Fate of natural estrogen conjugates in municipal sewage transport and treatment facilities. Sci. Total Environ. 302(1-3), 199-209.
9. Daughton, C. G. & Ternes, T. A. 1999 Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ. Health Perspect. 107, 907-938.
10. Desbrow, C., Routledge, E. J., Brighty, G. C., Sumpter, J. P. & Waldock, M. 1998 Identification of estrogenic chemicals in STW effluent. 1. Chemical fractionation and in vitro biological screening. Environ. Sci. Technol. 32(11), 1549-1558.
11. Drewes, J. E., Heberer, T. & Reddersen, K. 2002 Fate of pharmaceuticals during indirect potable reuse. Water Sci. Technol. 46(3), 73-80.
12. Halling-Sorensen, B., Nielsen, S. N., Lanzky, P. F., Ingerslev, F., Lutzhoft, H. C. H. & Jorgensen, S. E. 1998 Occurrence, fate and effects of pharmaceutical substances in the environment-a review. Chemosphere 36(2), 357-394.
13. Heberer, T. & Stan, H. J. 1997 Determination of clofibric acid and N-(Phenylsulfonyl)-sarcosine in sewage, river and drinking water. Int. J. Environ. Anal. Chem. 67(1-4), 113-123.
14. Hignite, C. & Azarnoff, D. L. 1977 Drugs and drug metabolites as environmental contaminants-chlorophenoxyisobutyrate and salicylic-acid in sewage water effluent. Life Sci. 20(2), 337-341.
15. Huber, M. M., Canonica, S., Park, G. Y. & Von Gunten, U. 2003 Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ. Sci. Technol. 37(5), 1016-1024.
16. Huber, M. M., Korhonen, S., Ternes, T. A. & von Gunten, U. 2005 Oxidation of pharmaceuticals during water treatment with chlorine dioxide. Water Res. 39(15), 3607-3617.
17. Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B. & Buxton, H. T. 2002 Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 36(6), 1202-1211.
18. LaBounty, J. F. & Burns, N. M. 2005 Characterization of Boulder Basin, Lake Mead, Nevada-Arizona, USA-based on analysis of 34 limnological parameters. Lake Reservoir Manage. 21(3), 277-307.
19. Roefer, P., Snyder, S., Zegers, R. E., Rexing, D. J. & Fronk, J. L. 2000 Endocrine-disrupting chemicals in a source water. J. Am. Water Works Assoc. 92(8), 52-58.
20. Routledge, E. J., Sheahan, D., Desbrow, C., Brighty, G. C., Waldock, M. & Sumpter, J. P. 1998 Identification of estrogenic chemicals in STW effluent. 2. In vivo responses in trout and roach. Environ. Sci. Technol. 32(11), 1559-1565.
21. Schueler, F. W. 1946 Sex hormonal action and chemical constitution. Science 103(2669), 221-223.
22. Snyder, S. A., Keith, T. L., Verbrugge, D. A., Snyder, E. M., Gross, T. S., Kannan, K. & Giesy, J. P. 1999 Analytical methods for detection of selected estrogenic compounds in aqueous mixtures. Environ. Sci. Technol. 33(16), 2814-2820.
23. Snyder, S. A., Villeneuve, D. L., Snyder, E.M. & Giesy, J. P. 2001 Identification and quantification of estrogen receptor agonists in wastewater effluents. Environ. Sci. Technol. 35(18), 3620-3625.
24. Snyder, S. A., Westerhoff, P., Yoon, Y. & Sedlak, D. L. 2003 Pharmaceuticals, personal care products, and endocrine disruptors in water: implications for the water industry. Environ. Eng. Sci. 20(5), 449-469.
25. Snyder, S. A., Wert, E. C., Rexing, D. J., Zegers, R. E. & Drury, D. D. 2006 Ozone oxidation of endocrine disruptors and pharmaceuticals in surface water and wastewater. Ozone-Sci. Eng. 28(6), 445-460.
26. Snyder, S. A., Adham, S., Redding, A.M., Cannon, F. S., DeCarolis, J., Oppenheimer, J.,Wert, E. C. & Yoon, Y. 2007a Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 202(1-3), 156-181.
27. Snyder, S. A., Wert, E. C., Lei, H. X., Westerhoff, P. & Yoon, Y. 2007b Removal of Edcs and Pharmaceuticals in Drinking and Reuse Treatment Processes. Awwa Research Foundation, Denver, CO, p. 331.
28. Stackelberg, P. E., Furlong, E. T., Meyer, M. T., Zaugg, S. D., Henderson, A. K. & Reissman, D. B. 2004 Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water treatment plant. Sci. Total Environ. 329(1-3), 99-113.
29. Stumm-Zollinger, E. & Fair, G. M. 1965 Biodegradation of steroid hormones. J. Water Pollut. Control Fed. 37, 1506-1510.
30. Takao, Y., Shimazu, M., Fukuda, M., Ishibashi, H., Nagae, M., Kohra, S., Tabira, Y., Ishibashi, Y. & Arizono, K. 2008 Seasonal and diurnal fluctuations in the concentrations of pharmaceuticals and personal care products (Ppcps) in residential sewage water. J. Health Sci. 54(2), 240-243.
31. Ternes, T. A. & Hirsch, R. 2000 Occurrence and behavior of X-ray contrast media in sewage facilities and the aquatic environment. Environ. Sci. Technol. 34(13), 2741-2748.
32. Ternes, T. A., Hirsch, R., Mueller, J. & Haberer, K. 1998 Methods for the determination of neutral drugs as well as betablockers and beta(2)-sympathomimetics in aqueous matrices using Gc/Ms and Lc/Ms/Ms. Fresenius J. Anal. Chem. 362(3), 329-340.
33. Ternes, T. A., Kreckel, P. & Mueller, J. 1999a Behaviour and occurrence of estrogens in municipal sewage treatment plants-II. Aerobic batch experiments with activated sludge. Sci. Total Environ. 225(1-2), 91-99.
34. Ternes, T. A., Stumpf, M., Mueller, J., Haberer, K., Wilken, R. D. & Servos, M. 1999b Behavior and occurrence of estrogens in municipal sewage treatment plants-I. Investigations in Germany, Canada and Brazil. Sci. Total Environ. 225(1-2), 81-90.
35. Ternes, T. A., Meisenheimer, M., McDowell, D., Sacher, F., Brauch, H. J., Gulde, B. H., Preuss, G., Wilme, U. & Seibert, N. Z. 2002 Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 36(17), 3855-3863.
36. Trenholm, R. A., Vanderford, B. J., Holady, J. C., Rexing, D. J. & Snyder, S. A. 2006 Broad range analysis of endocrine disruptors and pharmaceuticals using gas chromatography and liquid chromatography tandem mass spectrometry. Chemosphere 65(11), 1990-1998.
37. Vanderford, B. J., Pearson, R. A., Rexing, D. J. & Snyder, S. A. 2003 Analysis of endocrine disruptors, pharmaceuticals, and personal care products in water using liquid chromatography/tandem mass spectrometry. Anal. Chem. 75(22), 6265-6274.
38. Westerhoff, P., Yoon, Y., Snyder, S. & Wert, E. 2005 Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ. Sci. Technol. 39(17), 6649-6663.
39. Ye, Z. Q., Weinberg, H. S., & Meyer, M. T. 2007 Trace analysis of trimethoprim and sulfonamide, macrolide, quinolone, and tetracycline antibiotics in chlorinated drinking water using liquid chromatography electrospray tandem mass spectrometry. Anal. Chem. 79(3), 1135-1144.
40. Yoon, Y., Westerhoff, P., Snyder, S. A., Wert, E. C. & Yoon, J. 2007 Removal of endocrine disrupting compounds and pharmaceuticals by nanofiltration and ultrafiltration membranes. Desalination 202(1-3), 16-23.
41. Zwiener, C. & Frimmel, F. H. 2000 Oxidative treatment of pharmaceuticals in water. Water Res. 34(6), 1881-1885.